A naturally occurring feline model of head and neck squamous cell carcinoma

Pathology Research International

Volumn 2013, Issue , 2013, Pages

  Wypij, Jackie M ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84881432933     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2013/502197     Document Type: Article

References (64)

1. Tobinick E. L., The value of drug repositioning in the current pharmaceutical market. Drug News and Perspectives 2009 22 2 119 125 2-s2.0-65649112521 10.1358/dnp.2009.22.2.1343228
2. Kola I., The state of innovation in drug development. Clinical Pharmacology and Therapeutics 2008 83 2 227 230 2-s2.0-38349090575 10.1038/sj.clpt.6100479
3. Vail D. M., Thamm D. H., Teicher B. A., Spontaneous companion animal (pet) cancers. Tumor Models in Cancer Research: Cancer Drug Discovery and Development 2011 2nd New Jersey, NJ, USA Humana Press 353 373 10.1007/978-1-60761-968-0-15
4. Gordon I. K., Khanna C., Modeling opportunities in comparative oncology for drug development. ILAR Journal 2010 51 3 214 220 2-s2.0-79953151733
5. Paoloni M., Khanna C., Translation of new cancer treatments from pet dogs to humans. Nature Reviews Cancer 2008 8 2 147 156 2-s2.0-38549112058 10.1038/nrc2273 (Pubitemid 351161319)
6. Hansen K., Khanna C., Spontaneous and genetically engineered animal models: use in preclinical cancer drug development. European Journal of Cancer 2004 40 6 858 880 2-s2.0-1942518888 10.1016/j.ejca.2003.11.031 (Pubitemid 38519765)
7. Tannehill-Gregg S., Levine A., Rosol T., Feline head and neck squamous cell carcinoma: a natural model for the human disease and development of a mouse model. Veterinary and Comparative Oncology 2006 4 2 84 97
8. Khanna C., Lindblad-Toh K., Vail D., London C., Bergman P., Barber L., Breen M., Kitchell B., McNeil E., Modiano J. F., Niemi S., Comstock K. E., Ostrander E., Westmoreland S., Withrow S., The dog as a cancer model. Nature Biotechnology 2006 24 9 1065 1066 2-s2.0-33748516371 10.1038/nbt0906-1065b (Pubitemid 44359705)
9. Voskoglou-Nomikos T., Pater J. L., Seymour L., Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clinical Cancer Research 2003 9 11 4227 4239 2-s2.0-0141566685 (Pubitemid 37204044)
10. Shepherd A. J., Results of the 2006 AVMA survey of companion animal ownership in US pet-owning households. Journal of the American Veterinary Medical Association 2008 232 5 695 696 2-s2.0-41749116877 10.2460/javma.232.5. 695 (Pubitemid 351487402)
11. Elder J. H., Lin Y., Fink E., Grant C. K., Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. Current HIV Research 2010 8 1 73 80 2-s2.0-77949665270 10.2174/157016210790416389
12. Kenyon J. C., Lever A. M. L., The molecular biology of feline immunodeficiency virus (FIV). Viruses 2011 3 11 2192 2213 2-s2.0-82155191777 10.3390/v3112192
13. Henson M. S., O'Brien T. D., Feline models of type 2 diabetes mellitus. ILAR Journal 2006 47 3 234 242 2-s2.0-33745617095 (Pubitemid 43986032)
14. Hoenig M., The cat as a model for human nutrition and disease. Current Opinion in Clinical Nutrition and Metabolic Care 2006 9 5 584 588 2-s2.0-33747487423 10.1097/01.mco.0000241668.30761.69 (Pubitemid 44258033)
15. Martin C. K., Dirksen W. P., Shu S. T., Werbeck J. L., Thudi N. K., Yamaguchi M., Wolfe T. D., Heller K. N., Rosol T. J., Characterization of bone resorption in novel in vitro and in vivo models of oral squamous cell carcinoma. Oral Oncology 2012 48 6 491 499 2-s2.0-84855902029 10.1016/j.oraloncology.2011. 12.012
16. Wypij J. M., Fan T. M., Fredrickson R. L., Barger A. M., De Lorimier L. P., Charney S. C., In vivo and in vitro efficacy of zoledronate for treating oral squamous cell carcinoma in cats. Journal of Veterinary Internal Medicine 2008 22 1 158 163 2-s2.0-40549130382 10.1111/j.1939-1676.2007.0010.x (Pubitemid 351361466)
17. Tannehill-Gregg S., Kergosien E., Rosol T. J., Feline head and neck squamous cell carcinoma cell line: characterization, production of parathyroid hormone-related protein, and regulation by transforming growth factor- β In Vitro Cellular and Developmental Biology 2001 37 10 676 683 2-s2.0-0035661735 (Pubitemid 34001118)
18. Mognetti B., Di Carlo F., Berta G. N., Animal models in oral cancer research. Oral Oncology 2006 42 5 448 460 2-s2.0-33646143993 10.1016/j.oraloncology.2005.07.014
19. American Cancer Society, Cancer Facts and Figures (2012) 2012 Atlanta, Ga, USA American Cancer Society
20. Cooper J. S., Porter K., Mallin K., Hoffman H. T., Weber R. S., Ang K. K., Gay E. G., Langer C. J., National cancer database report on cancer of the head and neck: 10-year update. Head and Neck 2009 31 6 748 758 2-s2.0-67049156018 10.1002/hed.21022
21. Marretta J. J., Garrett L. D., Marretta S. M., Feline oral squamous cell carcinoma: an overview. Veterinary Medicine 2007 102 6 392 406 2-s2.0-34547408806 (Pubitemid 47168154)
22. Poirier V., Hotz B. K., Vail D., Straw R., Efficacy and toxicity of an accelerated hypofractionated radiation therapy protocol in cats with oral squamous cell carcinoma. Veterinary Radiology Ultrasound 2013 54 1 81 88
23. Stebbins K. E., Morse C. C., Goldschmidt M. H., Feline oral neoplasia: a ten-year survey. Veterinary Pathology 1989 26 2 121 128 2-s2.0-0024634070
24. Martin C. K., Tannehill-Gregg S. H., Wolfe T. D., Rosol T. J., Bone-invasive oral squamous cell carcinoma in cats: pathology and expression of parathyroid hormone-related protein. Veterinary Pathology 2011 48 1 302 312 2-s2.0-79951894706 10.1177/0300985810384414
25. Gardner D. G., Spontaneous squamous cell carcinomas of the oral region in domestic animals: a review and consideration of their relevance to human research. Oral Diseases 1996 2 2 148 154 2-s2.0-0030174292 (Pubitemid 26310905)
26. Bostock D. E., The prognosis in cats bearing squamous cell carcinoma. Journal of Small Animal Practice 1972 13 3 119 125 2-s2.0-0015311440
27. Bradley R. L., MacEwen E. G., Loar A. S., Mandibular resection for removal of oral tumors in 30 dogs and 6 cats. Journal of the American Veterinary Medical Association 1984 184 4 460 463 2-s2.0-0021762922
28. Salisbury S. K., Richardson D. C., Lantz G. C., Partial maxillectomy and premaxillectomy in the treatment of oral neoplasia in the dog and cat. Veterinary Surgery 1986 15 1 16 26
29. Reeves N. C. P., Turrel J. M., Withrow S. J., Oral squamous cell carcinoma in the cat. Journal of the American Animal Hospital Association 1993 29 5 438 441 2-s2.0-0027491449 (Pubitemid 23317638)
30. Northrup N. C., Selting K. A., Rassnick K. M., Kristal O., O'Brien M. G., Dank G., Dhaliwal R. S., Jagannatha S., Cornell K. K., Gieger T. L., Outcomes of cats with oral tumors treated with mandibulectomy: 42 cases. Journal of the American Animal Hospital Association 2006 42 5 350 360 2-s2.0-33947151428 (Pubitemid 46403560)
31. Hutson C. A., Willauer C. C., Walder E. J., Stone J. L., Klein M. K., Treatment of mandibular squamous cell carcinoma in cats by use of mandibulectomy and radiotherapy: seven cases (1987-1989). Journal of the American Veterinary Medical Association 1992 201 5 777 781 2-s2.0-0026917775
32. McDonald C., Looper J., Greene S., Response rate and duration associated with a 4Gy 5 fraction palliative radiation protocol. Veterinary Radiology Ultrasound 2012 53 3 358 364
33. Bregazzi V. S., LaRue S. M., Powers B. E., Fettman M. J., Ogilvie G. K., Withrow S. J., Response of feline oral squamous cell carcinoma to palliative radiation therapy. Veterinary Radiology and Ultrasound 2001 42 1 77 79 2-s2.0-0035226910 10.1111/j.1740-8261.2001.tb00907.x (Pubitemid 33669427)
34. Fidel J., Lyons J., Tripp C., Houston R., Wheeler B., Ruiz A., Treatment of oral squamous cell carcinoma with accelerated radiation therapy and concomitant carboplatin in cats. Journal of Veterinary Internal Medicine 2011 25 3 504 510 2-s2.0-79955515328 10.1111/j.1939-1676.2011.0721.x
35. Evans S. M., LaCreta F., Helfand S., VanWinkle T., Curran W. J. Jr., Brown D. Q., Hanks G., Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma. International Journal of Radiation Oncology Biology Physics 1991 20 4 703 708 2-s2.0-0025905601
36. Hayes A. M., Adams V. J., Scase T. J., Murphy S., Survival of 54 cats with oral squamous cell carcinoma in United Kingdom general practice. Journal of Small Animal Practice 2007 48 7 394 399 2-s2.0-34547280902 10.1111/j.1748-5827. 2007.00393.x (Pubitemid 47140949)
37. Marcu L. G., Yeoh E., A review of risk factors and genetic alterations in head and neck carcinogenesis and implications for current and future approaches to treatment. Journal of Cancer Research and Clinical Oncology 2009 135 10 1303 1314 2-s2.0-69049089826 10.1007/s00432-009-0648-7
38. Rautava J., Syrjanen S., Biology of human papillomavirus infections in head and neck carcinogenesis. Head and Neck Pathology 2012 6 supplement 1 S3 S15
39. Munday J. S., Howe L., French A., Squires R. A., Sugiarto H., Detection of papillomaviral DNA sequences in a feline oral squamous cell carcinoma. Research in Veterinary Science 2009 86 2 359 361 2-s2.0-60249098270 10.1016/j.rvsc.2008.07.005
40. O'Neill S. H., Newkirk K. M., Anis E. A., Brahmbhatt R., Frank L. A., Kania S. A., Detection of human papillomavirus DNA in feline premalignant and invasive squamous cell carcinoma. Veterinary Dermatology 2011 22 1 68 74 2-s2.0-78651445040 10.1111/j.1365-3164.2010.00912.x
41. Munday J. S., Knight C. G., French A. F., Evaluation of feline oral squamous cell carcinomas for p16CDKN2A protein immunoreactivity and the presence of papillomaviral DNA. Research in Veterinary Science 2011 90 2 280 283 2-s2.0-79951773866 10.1016/j.rvsc.2010.06.014
42. Munday J. S., Kiupel M., French A. F., Howe L., Amplification of papillomaviral DNA sequences from a high proportion of feline cutaneous in situ and invasive squamous cell carcinomas using a nested polymerase chain reaction. Veterinary Dermatology 2008 19 5 259 263 2-s2.0-52949100616 10.1111/j.1365-3164. 2008.00685.x
43. Bertone E. R., Snyder L. A., Moore A. S., Environmental and lifestyle risk factors for oral squamous cell carcinoma in domestic cats. Journal of Veterinary Internal Medicine 2003 17 4 557 562 (Pubitemid 37465315)
44. Snyder L. A., Bertone E. R., Jakowski R. M., Dooner M. S., Jennings-Ritchie J., Moore A. S., p53 expression and environmental tobacco smoke exposure in feline oral squamous cell carcinoma. Veterinary Pathology 2004 41 3 209 214 2-s2.0-2542459343 10.1354/vp.41-3-209 (Pubitemid 38686979)
45. Kalyankrishna S., Grandis J. R., Epidermal growth factor receptor biology in head and neck cancer. Journal of Clinical Oncology 2006 24 17 2666 2672 2-s2.0-33748188459 10.1200/JCO.2005.04.8306 (Pubitemid 46622088)
46. Looper J., Malarkey D., Ruslander D., Proulx D., Thrall D., Epidermal growth factor receptor expression in feline oral squamous cell carcinomas. Veterinary and Comparative Oncology 2006 4 1 33 40
47. Yoshikawa H., Ehrhart E. J., Charles J., Thamm D., Larue S., Immunohistochemical characterization of feline oral squamous cell carcinoma. American Journal of Veterinary Research 2012 73 11 1801 1806
48. Bergkvist G. T., Argyle D. J., Morrison L., Macintyre N., Hayes A., Yool D. A., Expression of epidermal growth factor receptor (EGFR) and Ki67 in feline oral squamous cell carcinomas (FOSCC). Veterinary and Comparative Oncology 2011 9 2 106 117 2-s2.0-79955986559 10.1111/j.1476-5829.2010.00239.x
49. Bergkvist G. T., Argyle D. J., Pang L. Y., Muirhead R., Yool D. A., Studies on the inhibition of feline EGFR in squamous cell carcinoma: enhancement of radiosensitivity and rescue of resistance to small molecule inhibitors. Cancer Biology and Therapy 2011 11 11 927 937 2-s2.0-79957810205 10.4161/cbt.11.11.15525
50. Pang L. Y., Bergkvist G. T., Arias A. C., Yool D. A., Muirhead R., Argyle D. J., Identification of tumour initiating cells in feline head and neck squamous cell carcinoma and evidence for gefitinib induced epithelial to mesenchymal transition. The Veterinary Journal 2012 193 1 46 52
51. Kyzas P. A., Cunha I. W., Ioannidis J. P. A., Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis. Clinical Cancer Research 2005 11 4 1434 1440 2-s2.0-14644411058 10.1158/1078-0432.CCR-04-1870 (Pubitemid 40315223)
52. Wypij J. M., Anti-neoplastic effects of zoledronate in feline oral squamous cell carcinoma [Masters] 2009 Urbana, Ill, USA University of Illinois at Urbana-Champaign
53. Gallo O., Masini E., Bianchi B., Bruschini L., Paglierani M., Franchi A., Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma. Human Pathology 2002 33 7 708 714 2-s2.0-0036650402 10.1053/hupa.2002.125376 (Pubitemid 34953350)
54. Pannone G., Bufo P., Caiaffa M. F., Serpico R., Lanza A., Lo Muzio L., Rubini C., Staibano S., Petruzzi M., De Benedictis M., Tursi A., De Rosa G., Macchia L., Cyclooxygenase-2 expression in oral squamous cell carcinoma. International Journal of Immunopathology and Pharmacology 2004 17 3 273 282 2-s2.0-8344285096 (Pubitemid 39481670)
55. Beam S. L., Rassnick K. M., Moore A. S., McDonough S. P., An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Veterinary Pathology 2003 40 5 496 500 2-s2.0-0642344639 10.1354/vp.40-5-496 (Pubitemid 38393554)
56. DiBernardi L., Doré M., Davis J. A., Owens J. G., Mohammed S. I., Guptill C. F., Knapp D. W., Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment. Prostaglandins Leukotrienes and Essential Fatty Acids 2007 76 4 245 250 2-s2.0-34247177094 10.1016/j.plefa.2007.01.006 (Pubitemid 46590012)
57. Hayes A., Scase T., Miller J., Murphy S., Sparkes A., Adams V., COX 2 expression in feline oral squamous cell carcinoma (FOSCC)-an immunohistochemical study and analysis of survival. Veterinary and Comparative Oncology 2005 3 1 44 45 10.1111/j.1476-5810.2005.0064t.x
58. Heller D. A., Clifford C. A., Goldschmidt M. H., Holt D. E., Manfredi M. J., Sorenmo K. U., Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor. Veterinary Pathology 2005 42 3 350 353 2-s2.0-19044377445 10.1354/vp.42-3-350 (Pubitemid 40711195)
59. Wakshlag J. J., Peters-Kennedy J., Bushey J. J., Loftus J. P., 5-lipoxygenase expression and tepoxalin-induced cell death in squamous cell carcinomas in cats. American Journal of Veterinary Research 2011 72 10 1369 1377 2-s2.0-80053639290 10.2460/ajvr.72.10.1369
60. Cabelguenne A., Blons H., De Waziers I., Carnot F., Houllier A., Soussi T., Brasnu D., Beaune P., Laccourreye O., Laurent-Puig P., p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series. Journal of Clinical Oncology 2000 18 7 1465 1473 2-s2.0-0034086197 (Pubitemid 30205392)
61. Teifke J. P., Lohr C. V., Immunohistochemical detection of P53 overexpression in paraffin wax-embedded squamous cell carcinomas of cattle, horses, cats and dogs. Journal of Comparative Pathology 1996 114 2 205 210 2-s2.0-0029878556 10.1016/S0021-9975(96)80010-7 (Pubitemid 26121769)
62. Slootweg P. J., Koole R., Hordijk G. J., The presence of p53 protein in relation to Ki-67 as cellular proliferation marker in head and neck squamous cell carcinoma and adjacent dysplastic mucosa. European Journal of Cancer B 1994 30 2 138 141 2-s2.0-0028347978 10.1016/0964-1955(94)90066-3 (Pubitemid 24136734)
63. Silva S. D., Agostini M., Nishimoto I. N., Coletta R. D., Alves F. A., Lopes M. A., Kowalski L. P., Graner E., Expression of fatty acid synthase, ErbB2 and Ki-67 in head and neck squamous cell carcinoma. A clinicopathological study. Oral Oncology 2004 40 7 688 696 2-s2.0-2542468775 10.1016/j.oraloncology. 2004.01.004 (Pubitemid 38686905)
64. Martin C. K., Werbeck J. L., Thudi N. K., Lanigan L. G., Wolfe T. D., Toribio R. E., Rosol T. J., Zoledronic acid reduces bone loss and tumor growth in an orthotopic xenograft model of osteolytic oral squamous cell carcinoma. Cancer Research 2010 70 21 8607 8616 2-s2.0-78449270310 10.1158/0008-5472.CAN- 10-0850